Pr ecis: These findings validate a novel MRI method for imaging tumor hypoxia that fulfills an unmet clinical need and can be readily translated into clinical studies. 
Pr ecis: These findings provide preclinical evidence that miR34a suppresses triple-negative breast cancer, supporting investigation to develop it as a targeted therapeutic strategy currently lacking in this disease.
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Pr ecis: This study shows how a genetic skin disorder rapidly progresses to an aggressive skin cancer, identifying promising therapeutic targets within the compromised dermal microenvironment that may limit carcinogenesis. 
ABOUT THE COVER
The longitudinal relaxation rate of protons is increased when subjects switch from breathing air to inhaling 100% oxygen. This effect when detected by MRI scanning is termed oxygenenhanced MRI. It was found that this technique-in combination with measurements of perfusion-was capable of in vivo mapping of tumor hypoxia, distinguishing tumor subregions with low oxygen tension from well-oxygenated tumor tissue. Pimonidazole adduct formation immunofluorescence was used to validate these findings. Oxygen-enhanced MRI can be performed readily on conventional clinical scanners, so the technique has potential for rapid clinical translation. For details, see article by O'Connor and colleagues on page 787.
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